You are hereAurobindo Pharma

Aurobindo Pharma


Aurobindo Pharma gets USFDA nod to market generic Osteoporosis drug

Aurobindo Pharma said it has received final approval from USFDA to manufacture and market generic version of Risedronate Sodium tablets, used in the treatment of Osteoporosis, in the American market.


Aurobindo Pharma receive USFDA approval for Tramadol Hydrochloride

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market  Tramadol Hydrochloride Extended -release Tablets USP, 100 mg, 200 mg and 300 mg.


Aurobindo Pharma Receives USFDA Approval For Anti-Psychotic Drugs

Hyderabad-based Aurobindo Pharma received the final approval from the US Food and Drug Administration to manufacture and market generic Aripiprazole tablets used for treatment of psychotic conditions in the American market. The approval is for the tablets in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg and 30mg.


USFDA approves Marketing of Aurobindo Pharma’s Ulcer Drug

The US Food and Drug Administration (USFDA) has approved Aurobindo Pharma to market generic version of Prilosec delayed-release capsules used to treat ulcer.


Aurobindo Pharma receive US FDA approval for manufacture and market entacapone tablets and azithromycin for injection

Aurobindo Pharma got final approvals from the US FDA of azithromycin for injection USP, 500mg /vial and entacapone tablets. Azithromycin for injection USP, 500mg/vial is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zithromax (azithromycin for injection) 500mg/vial of Pfizer, Inc. Azithromycin for injection, USP is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions such as community-acquired pneumonia and pelvic inflammatory disease.


Job as Technical Assistants, Executives for department of Production, QC, QA in Aurobindo Pharma | Walk in

Aurobindo Pharma Limited (API) is a $2Bn + company with global operations in US, Europe, Asia. Africa, CIS etc. having multiple plants and markets spread across 3 continents with regulatory approvals from USFDA, UKMHRA etc.
API invites applicants, for the following positions for its automated and most modem Oral Solid Dosages Formulation Units.

Post: Technical Assistants, Executives


US FDA approved Aurobindo anesthesia supplement drug product

Aurobindo Pharma has received the final approval from the US Food and Drug Administration to manufacture and market Atracurium Besylate injection in single and multi-dose vials in the US market.


Job as Clinical Research Purchase Manager in Aurobindo Pharma

Aurobindo Pharma had gone public in 1995 by listing its shares in various stock exchanges in the country. The company is the market leader in semi-synthetic penicillin drugs. It has a presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio-vascular, gastroenterology, etc.
Over the years, the Aurobindo Pharma has evolved into a knowledge driven company. It is R&D focused, has a multi-product portfolio with multi-country manufacturing facilities, and is becoming a marketing conglomerate across the world.


Vacancies @ Aurobindo Pharma as Manager-CQA, GM-F&D, Manager Production, Manager-QA, QC Manager

Aurobindo Pharma had gone public in 1995 by listing its shares in various stock exchanges in the country. The company is the market leader in semi-synthetic penicillin drugs. It has a presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio-vascular, gastroenterology, etc.
Over the years, the Aurobindo Pharma has evolved into a knowledge driven company. It is R&D focused, has a multi-product portfolio with multi-country manufacturing facilities, and is becoming a marketing conglomerate across the world.


Require Country Manager (Africa, South East Asia & Middle East) @ Aurobindo Pharma- 5 posts

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.